Provided by Tiger Trade Technology Pte. Ltd.

Amgen

440.34
-1.9000-0.43%
Post-market: 437.15-3.1900-0.72%18:56 EDT
Volume:2.29M
Turnover:1.01B
Market Cap:237.11B
PE:27.35
High:442.89
Open:441.00
Low:438.24
Close:442.24
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.94
T/O Rate:0.43%
Dividend:9.80
Dividend Rate:2.23%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.29
PE(LYR):30.94

Loading ...

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Yesterday

Political and General News Events from August 25

Reuters
·
Aug 25

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Aug 25

Political and General News Events from August 24

Reuters
·
Aug 24

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

TIPRANKS
·
Aug 22

Amgen is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 21

Amgen price target raised to $457 from $427 at Piper Sandler

TIPRANKS
·
Aug 20

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Amgen Rises 3.05% in Regular Trading, Morgan Stanley and Mizuho Raise Target Prices Amid Biotech Sector Strength

Market Focus
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Amgen is Maintained at Buy by Argus Research

Dow Jones
·
Aug 19

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Reuters
·
Aug 19

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS
·
Aug 19

Morgan Stanley Adjusts Price Target on Amgen to $362 From $351, Keeps Equalweight Rating

MT Newswires Live
·
Aug 19